Tom Frohlich

Tom Frohlich

Chief Executive Officer at JADE BIOSCIENCES, INC.
50 year
Health Technology
Consumer Services
Finance

Profile

Tom Frohlich was the founder of Chinook Therapeutics, Inc., founded in 2019, where the title held was Chief Operating Officer from 2021 to 2023.
Mr. Frohlich is currently Chief Executive Officer & Director at Jade Biosciences, Inc. (United States) starting in 2024 and Chief Executive Officer & Director at Jade Biosciences, Inc. starting in 2025.
Former jobs include Vice President-Business Development at Arbutus Biopharma Corp.
from 2016 to 2018, Senior Vice President-Business Development at Inception Sciences, Inc. in 2018, and Entrepreneur-in-Residence at Versant Ventures Canada Ltd. Education includes an MBA from the University of Oxford in 2007 and an undergraduate degree from the University of Victoria in 1998.

Tom Frohlich active positions

CompaniesPositionStart
JADE BIOSCIENCES, INC. Chief Executive Officer 28/04/2025

Former positions of Tom Frohlich

CompaniesPositionEnd
CHINOOK THERAPEUTICS, INC. Founder 01/10/2023
Corporate Officer/Principal 01/12/2018
ARBUTUS BIOPHARMA CORPORATION Corporate Officer/Principal 01/03/2018
Private Equity Investor -
See the detail of Tom Frohlich's experience

Training of Tom Frohlich

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

90

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Health Technology

Finance

Health Technology

Health Technology